MEDP
NASDAQMedpace Holdings Inc.
Website
News25/Ratings12
News · 26 weeks57+14%
2025-10-262026-04-19
Mix2490d
- Insider8(33%)
- SEC Filings7(29%)
- Analyst5(21%)
- Earnings3(13%)
- Other1(4%)
Latest news
25 items- SECSEC Form 10-Q filed by Medpace Holdings Inc.10-Q - Medpace Holdings, Inc. (0001668397) (Filer)
- SECMedpace Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits8-K - Medpace Holdings, Inc. (0001668397) (Filer)
- PRMedpace Holdings, Inc. Reports First Quarter 2026 ResultsRevenue of $706.6 million in the first quarter of 2026 increased 26.5% from revenue of $558.6 million for the comparable prior-year period, representing a backlog conversion rate of 23.3%. Net new business awards were $618.4 million in the first quarter of 2026, representing an increase of 23.7% from net new business awards of $500.0 million for the comparable prior-year period, which resulted in a net book-to-bill ratio of 0.88x. First quarter of 2026 GAAP net income was $123.9 million, or $4.28 per diluted share, versus GAAP net income of $114.6 million, or $3.67 per diluted share, for the comparable prior-year period. Net income margin was 17.5% and 20.5% for the first quarter of
- INSIDERSEC Form 4 filed by Mccarthy Cornelius P. Iii4 - Medpace Holdings, Inc. (0001668397) (Issuer)
- INSIDERSEC Form 4 filed by Kraft Robert O.4 - Medpace Holdings, Inc. (0001668397) (Issuer)
- INSIDERSEC Form 4 filed by Carley Brian T4 - Medpace Holdings, Inc. (0001668397) (Issuer)
- SECSEC Form DEFA14A filed by Medpace Holdings Inc.DEFA14A - Medpace Holdings, Inc. (0001668397) (Filer)
- SECSEC Form DEF 14A filed by Medpace Holdings Inc.DEF 14A - Medpace Holdings, Inc. (0001668397) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Medpace Holdings Inc.SCHEDULE 13G/A - Medpace Holdings, Inc. (0001668397) (Subject)
- PRMedpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026Medpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace") today announced that it will report its first quarter 2026 financial results after the market close on Wednesday, April 22, 2026. The Company will host a conference call the following morning, Thursday, April 23, 2026, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested parties must register in advance by clicking on this link. While it is not required, it is recommended you join 10 minutes prior to the event start. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique PIN that can be
- INSIDERSEC Form 4 filed by Burwig Susan E4 - Medpace Holdings, Inc. (0001668397) (Issuer)
- INSIDERSEC Form 4 filed by Geiger Jesse J4 - Medpace Holdings, Inc. (0001668397) (Issuer)
- SECSEC Form PRE 14A filed by Medpace Holdings Inc.PRE 14A - Medpace Holdings, Inc. (0001668397) (Filer)
- ANALYSTMedpace upgraded by Barclays with a new price targetBarclays upgraded Medpace from Underweight to Equal Weight and set a new price target of $500.00
- ANALYSTRBC Capital Mkts initiated coverage on Medpace with a new price targetRBC Capital Mkts initiated coverage of Medpace with a rating of Outperform and set a new price target of $522.00
- INSIDERGeneral Counsel & Corp. Secy. Ewald Stephen P exercised 3,500 shares at a strike of $138.87, increasing direct ownership by 26% to 16,843 units (SEC Form 4)4 - Medpace Holdings, Inc. (0001668397) (Issuer)
- ANALYSTMedpace upgraded by TD Cowen with a new price targetTD Cowen upgraded Medpace from Sell to Hold and set a new price target of $419.00
- INSIDERDirector Carley Brian T exercised 6,472 shares at a strike of $54.99, increasing direct ownership by 25% to 32,753 units (SEC Form 4)4 - Medpace Holdings, Inc. (0001668397) (Issuer)
- INSIDERExec. VP, Operations Burwig Susan E exercised 10,984 shares at a strike of $107.93, increasing direct ownership by 23% to 58,484 units (SEC Form 4)4 - Medpace Holdings, Inc. (0001668397) (Issuer)
- ANALYSTMedpace upgraded by Jefferies with a new price targetJefferies upgraded Medpace from Hold to Buy and set a new price target of $560.00
- SECSEC Form 10-K filed by Medpace Holdings Inc.10-K - Medpace Holdings, Inc. (0001668397) (Filer)
- ANALYSTMedpace upgraded by Robert W. Baird with a new price targetRobert W. Baird upgraded Medpace from Neutral to Outperform and set a new price target of $564.00
- SECMedpace Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Medpace Holdings, Inc. (0001668397) (Filer)
- PRMedpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 ResultsRevenue of $708.5 million in the fourth quarter of 2025 increased 32.0% from revenue of $536.6 million for the comparable prior-year period, representing a backlog conversion rate of 23.6%. Net new business awards were $736.6 million in the fourth quarter of 2025, representing an increase of 39.1% from net new business awards of $529.7 million for the comparable prior-year period, which resulted in a net book-to-bill ratio of 1.04x. Fourth quarter of 2025 GAAP net income was $135.1 million, or $4.67 per diluted share, versus GAAP net income of $117.0 million, or $3.67 per diluted share, for the comparable prior-year period. Net income margin was 19.1% and 21.8% for the fourth quarter
- INSIDERDirector Mccarthy Cornelius P. Iii converted options into 49 shares, increasing direct ownership by 0.48% to 10,295 units (SEC Form 4)4 - Medpace Holdings, Inc. (0001668397) (Issuer)